Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1387.00
7.00
(0.51%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr Reddy’s Mexico facility gets USFDA warning letter
>>
Dr Reddy’s Lab launches three products in the US market
>>
Dr Reddy's polypill halves heart disease and stroke risk in trial
>>
Dr Reddy's launches Fexofenadine HCl in US
>>
DRL's unit in pact with Valeant Pharma
>>
Dr Reddy's completes acquisition of GSK's penicillin facility in US
>>
Dr Reddy’s launches anti-allergy tablets in US
>>
Dr Reddy’s may launch 3 new drugs in the US and to issue bonus debentures worth Rs 520 crore
>>
Dr Reddy’s eyes $1 bn revenue in next 3 years
>>
US court clears way for launch of Allegra D24 by Dr Reddy’s
<<
<
142
143
144
...145
>
>>